The Pharmacological Sciences Training Program provides training through the Pharmacology Track of the UCSD Biomedical Sciences (BMS) Graduate Program and seeks to provide trainees with a contemporary education in Pharmacology and state-of-the-art research training in Pharmacological Sciences. Didactic and experiential efforts prepare graduates for a wide range of career opportunities in academia and industry, where their broad scope of training in pharmacology, integrated with sister disciplines of physiology and molecular sciences, will be valued. Faculty interests and training areas emphasize understanding signaling pathways that are relevant to disease, elucidating new targets for drug action and using novel approaches to identify chemicals that modulate drug targets. The Training Faculty work in interdigitating areas, the largest of which is Signal Transduction. This category encompasses work on receptors and G-proteins, kinases and phosphatases, intracellular signaling pathways, cancer and growth regulation. Other major areas include Cardiovascular Science, Neuroscience, Drug Discovery and Protein Structure, Pharmacogenomics and Genetics, Drug Metabolism and Transport, and Endocrinology and Metabolism. Trainees take the Molecules to Organisms core course and Seminar course together with other BMS students in the Fall of year one. Subsequent courses given by the Pharmacology Track are required for all students in the Training Program (and encouraged for Trainees associated with the Program). Requirements are: Two quarters of the Drugs and Disease course, Seminars in Pharmacology, and three elective courses: one in a quantitative area, one an organ systems lab course and one dealing with pharmacokinetics or drug disposition. All Trainees participate in weekly Department of Pharmacology Research Discussions and host luncheons with seminar speakers. Two yearly Retreats provide Trainees with opportunities to interact with faculty and present their research progress. The Training Grant is in its 29th year and supports 15 trainees (approved for 16). Trainees are supported by the Training Grant for 2-3 years and obtain their Ph.D. in an average 5.6 years. We request an increase to 19 stipends based on continuously increasing faculty and graduate student growth at UCSD, the high quality of students we attract, and the opening and expansion of the Skaggs School of Pharmacy and Pharmaceutical Sciences Relevance: We train students in pharmacology so they will find better drugs to treat disease. Trainees learn basic science and do cutting edge research leading to an understanding of how the body works, what happens when diseases develop, how to intervene so that these changes might be prevented or blocked, and how to develop improved therapeutic agents to correct the dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007752-35
Application #
8511678
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
1979-07-01
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
35
Fiscal Year
2013
Total Cost
$537,356
Indirect Cost
$29,716
Name
University of California San Diego
Department
Pharmacology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Groves, Aran; Kihara, Yasuyuki; Jonnalagadda, Deepa et al. (2018) A Functionally Defined In Vivo Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes (ieAstrocytes). eNeuro 5:
Callender, Julia A; Yang, Yimin; Lordén, Gema et al. (2018) Protein kinase C? gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation. Proc Natl Acad Sci U S A 115:E5497-E5505
Grimsey, Neil J; Narala, Rachan; Rada, Cara C et al. (2018) A Tyrosine Switch on NEDD4-2 E3 Ligase Transmits GPCR Inflammatory Signaling. Cell Rep 24:3312-3323.e5
Dravis, Christopher; Chung, Chi-Yeh; Lytle, Nikki K et al. (2018) Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity. Cancer Cell 34:466-482.e6
Caliman, Alisha D; Miao, Yinglong; McCammon, James A (2018) Mapping the allosteric sites of the A2A adenosine receptor. Chem Biol Drug Des 91:5-16
Al-Bassam, Mahmoud M; Kim, Ji-Nu; Zaramela, Livia S et al. (2018) Optimization of carbon and energy utilization through differential translational efficiency. Nat Commun 9:4474
Zhao, Xuefeng; Deng, Peng; Iglesias-Bartolome, Ramiro et al. (2018) Expression of an active G?s mutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance. Proc Natl Acad Sci U S A 115:E428-E437
Markmiller, Sebastian; Soltanieh, Sahar; Server, Kari L et al. (2018) Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules. Cell 172:590-604.e13
Suetomi, Takeshi; Willeford, Andrew; Brand, Cameron S et al. (2018) Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II ? Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling. Circulation 138:2530-2544
Arakaki, Aleena K S; Pan, Wen-An; Lin, Huilan et al. (2018) The ?-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling. J Biol Chem 293:3350-3362

Showing the most recent 10 out of 355 publications